title: [Cytostatic-assisted myelosuppression using dicarbamin, an oral hematoprotector (experimental study)].
authors.forename: I D
authors.initials: ID
authors.lastname: Treshchalin
authors.forename: D A
authors.initials: DA
authors.lastname: Bodiagin
authors.forename: E R
authors.initials: ER
authors.lastname: Pereverzeva
authors.forename: M I
authors.initials: MI
authors.lastname: Treshchalin
authors.forename: V E
authors.initials: VE
authors.lastname: Nebol'sin
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001853:Bone Marrow / Q000187:drug effects*; D002208:Caproates; D016190:Carboplatin / Q000494:pharmacology; D002945:Cisplatin / Q000494:pharmacology; D003520:Cyclophosphamide / Q000494:pharmacology; D054697:Cytostatic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D007093:Imidazoles / Q000008:administration & dosage / Q000494:pharmacology*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008297:Male; D051379:Mice
chemical_list: D002208:Caproates; D054697:Cytostatic Agents; D007093:Imidazoles; D007166:Immunosuppressive Agents; C539419:pentanedioic acid imidazolyl ethanamide; D003520:Cyclophosphamide; D016190:Carboplatin; D002945:Cisplatin